These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37269615)

  • 1. Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls.
    Bloem AEM; Houben-Wilke S; Mostard RLM; Stoot N; Janssen DJA; Franssen FME; Custers JWH; Spruit MA
    Heart Lung; 2023; 61():136-146. PubMed ID: 37269615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases.
    Atkins CP; Gilbert D; Brockwell C; Robinson S; Wilson AM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):130-8. PubMed ID: 27537715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient confidence and quality of life in idiopathic pulmonary fibrosis and sarcoidosis.
    Kotecha J; Atkins C; Wilson A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):341-348. PubMed ID: 28079846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care.
    Thickett D; Voorham J; Ryan R; Jones R; Coker R; Wilson AM; Yang S; Ow MY; Raju P; Chaudhry I; Hardjojo A; Carter V; Price DB
    BMJ Open; 2020 May; 10(5):e034428. PubMed ID: 32474425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis.
    Bloem AEM; Mostard RLM; Stoot N; Vercoulen JH; Peters JB; Spruit MA
    J Thorac Dis; 2021 Aug; 13(8):4872-4884. PubMed ID: 34527326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?
    Collins BF; McClelland RL; Ho LA; Mikacenic CR; Hayes J; Spada C; Raghu G
    Respir Med; 2018 Nov; 144S():S20-S27. PubMed ID: 30166087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis.
    Bloem AEM; Mostard RLM; Stoot N; Vercoulen JH; Peters JB; Janssen DJA; Custers JWH; Spruit MA
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32325989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
    Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type D or 'distressed' personality in sarcoidosis and idiopathic pulmonary fibrosis.
    Elfferich MD; De Vries J; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):65-71. PubMed ID: 21796893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Activation for Self-Management in Patients with Idiopathic Pulmonary Fibrosis or Sarcoidosis.
    Bloem AEM; Mostard RLM; Stoot N; Custers JWH; Vooijs M; Janssen DJA; van 't Hul AJ; Spruit MA
    Respiration; 2022; 101(1):76-83. PubMed ID: 34515234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective cough frequency in Idiopathic Pulmonary Fibrosis.
    Key AL; Holt K; Hamilton A; Smith JA; Earis JE
    Cough; 2010 Jun; 6():4. PubMed ID: 20565979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 in sarcoidosis.
    Salez F; Gosset P; Copin MC; Lamblin Degros C; Tonnel AB; Wallaert B
    Eur Respir J; 1998 Oct; 12(4):913-9. PubMed ID: 9817168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Prasse A; Kreuter M; Johow J; Rabe KF; Bonella F; Bonnet R; Grohe C; Held M; Wilkens H; Hammerl P; Koschel D; Blaas S; Wirtz H; Ficker JH; Neumeister W; Schönfeld N; Claussen M; Kneidinger N; Frankenberger M; Hummler S; Kahn N; Tello S; Freise J; Welte T; Neuser P; Günther A;
    Lancet Respir Med; 2021 May; 9(5):476-486. PubMed ID: 33798455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis.
    Kamp JC; Neubert L; Stark H; Hinrichs JB; Boekhoff C; Seidel AD; Ius F; Haverich A; Gottlieb J; Welte T; Braubach P; Laenger F; Hoeper MM; Kuehnel MP; Jonigk DD
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.